FI822921L - PROCEDURE FOR FRAMSTATION OF AV / 3H / -IMIDAZO- / 5,1-D / -1,2,3,5-TETRAZINE-4-ONDERIVAT MED TERAPEUTISVERKAN - Google Patents

PROCEDURE FOR FRAMSTATION OF AV / 3H / -IMIDAZO- / 5,1-D / -1,2,3,5-TETRAZINE-4-ONDERIVAT MED TERAPEUTISVERKAN

Info

Publication number
FI822921L
FI822921L FI822921A FI822921A FI822921L FI 822921 L FI822921 L FI 822921L FI 822921 A FI822921 A FI 822921A FI 822921 A FI822921 A FI 822921A FI 822921 L FI822921 L FI 822921L
Authority
FI
Finland
Prior art keywords
terapeutisverkan
onderivat
framstation
tetrazine
imidazo
Prior art date
Application number
FI822921A
Other languages
Finnish (fi)
Other versions
FI822921A0 (en
FI73434B (en
FI73434C (en
Inventor
Edward Lunt
Malcolm Francis Graham Stevens
Robert Stone
Kenneth Robert Harr Wooldringe
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of FI822921A0 publication Critical patent/FI822921A0/en
Publication of FI822921L publication Critical patent/FI822921L/en
Publication of FI73434B publication Critical patent/FI73434B/en
Application granted granted Critical
Publication of FI73434C publication Critical patent/FI73434C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI822921A 1981-08-24 1982-08-23 Process for Preparation of 3H-imidazo-5,1-d FI73434C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24
GB8125791 1981-08-24

Publications (4)

Publication Number Publication Date
FI822921A0 FI822921A0 (en) 1982-08-23
FI822921L true FI822921L (en) 1983-02-25
FI73434B FI73434B (en) 1987-06-30
FI73434C FI73434C (en) 1987-10-09

Family

ID=10524141

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822921A FI73434C (en) 1981-08-24 1982-08-23 Process for Preparation of 3H-imidazo-5,1-d

Country Status (29)

Country Link
JP (1) JPS5843975A (en)
KR (1) KR890000094B1 (en)
AT (1) AT380256B (en)
AU (1) AU571430B2 (en)
BE (1) BE894175A (en)
CA (1) CA1197247A (en)
CH (1) CH655114A5 (en)
DE (2) DE3231255A1 (en)
DK (1) DK161147C (en)
ES (1) ES8400438A1 (en)
FI (1) FI73434C (en)
FR (1) FR2511679A1 (en)
GB (1) GB2104522B (en)
GE (1) GEP19960641B (en)
GR (1) GR76863B (en)
HU (1) HU186107B (en)
IE (1) IE53408B1 (en)
IL (1) IL66606A (en)
IT (1) IT1152505B (en)
LT (1) LT2436B (en)
LU (1) LU84347A1 (en)
LV (2) LV5511A3 (en)
NL (2) NL192739C (en)
NZ (1) NZ201668A (en)
OA (1) OA07174A (en)
SE (1) SE448543B (en)
SU (1) SU1447284A3 (en)
UA (1) UA5971A1 (en)
ZA (1) ZA826120B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
FR2531958B1 (en) * 1982-08-17 1986-10-31 May & Baker Ltd NEW DERIVATIVES
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
BRPI0417117A (en) * 2003-12-30 2007-03-06 Chemagis Ltd crystallized temozolomide, crystallized temozolomide preparation process, pharmaceutical composition, method of producing medicament containing temozolomide and method of treating a medical condition for which thermozolomide is beneficial
US20090036435A1 (en) 2005-01-21 2009-02-05 Astex Therapeutics Limited Pharmaceutical Compounds
AR060635A1 (en) 2006-04-27 2008-07-02 Banyu Pharma Co Ltd DERIVATIVES OF 1,2-DIHIDRO-3H-PIRAZOLO [3,4-D] PIRIMIDIN-3-ONA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THEIR USE IN THE TREATMENT OF CANCER
JP2008081492A (en) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd New aminopyridine derivative having aurora a selective inhibitory action
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
CA2703489A1 (en) 2007-10-23 2009-04-30 Banyu Pharmaceutical Co., Ltd. Pyridone-substituted-dihydropyrazolopyrimidinone derivative
PE20091101A1 (en) * 2007-12-18 2009-07-26 Pharminox Ltd 3-SUBSTITUTED-4-OXO-3,4-DIHYDRO-IMIDAZO [5,1-d] [1,2,3,5-TETRACINE-8-CARBOXYL ACID AMIDES AND ITS USE
CA2744560A1 (en) * 2008-11-24 2010-05-27 Reliance Life Sciences Pvt. Ltd. Process for the preparation of tetrazine derivatives
EP2403339B1 (en) 2009-03-06 2017-01-18 Merck Sharp & Dohme Corp. Combination cancer therapy with an akt inhibitor and other anticancer agents
EP2445915B1 (en) 2009-06-23 2016-04-20 Pharminox Limited 3-substituted-8-substituted-3h imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use
RU2462466C1 (en) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Substituted azolo[1,2,4,5]tetrazines - inhibitors of antibacterial serine-threonine protein kinases
US20140271657A1 (en) 2011-10-12 2014-09-18 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
CN109195593A (en) 2016-03-15 2019-01-11 奥莱松基因组股份有限公司 For treating the combination of the LSD1 inhibitor of solid tumor
KR101847342B1 (en) * 2017-05-08 2018-04-11 (주)센텍코리아 Wearable body fat burning measurement device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (en) * 1979-08-09 1981-02-26 Basf Ag Pyrrolo-, pyrazolo-, imidazo- and thiazolo-tetrazin-4-one derivs. - prepd. from amino-azole cpds. by diazotisation and reaction with isocyanate

Also Published As

Publication number Publication date
GR76863B (en) 1984-09-04
FR2511679B1 (en) 1985-02-01
SU1447284A3 (en) 1988-12-23
DE19975037I2 (en) 2001-06-13
FR2511679A1 (en) 1983-02-25
IL66606A (en) 1987-07-31
NZ201668A (en) 1985-08-16
JPS5843975A (en) 1983-03-14
CA1197247A (en) 1985-11-26
KR890000094B1 (en) 1989-03-07
DK377882A (en) 1983-02-25
BE894175A (en) 1983-02-23
DE3231255A1 (en) 1983-03-03
IE822026L (en) 1983-02-24
SE448543B (en) 1987-03-02
NL192739C (en) 1998-01-06
FI822921A0 (en) 1982-08-23
DK161147C (en) 1991-11-18
CH655114A5 (en) 1986-03-27
NL8203286A (en) 1983-03-16
ES515176A0 (en) 1983-11-01
ZA826120B (en) 1983-07-27
IT1152505B (en) 1987-01-07
NL192739B (en) 1997-09-01
OA07174A (en) 1984-04-30
AU8749382A (en) 1983-03-03
DK161147B (en) 1991-06-03
KR840001175A (en) 1984-03-28
SE8204817D0 (en) 1982-08-23
LV5511A3 (en) 1994-03-10
FI73434B (en) 1987-06-30
GB2104522A (en) 1983-03-09
FI73434C (en) 1987-10-09
ES8400438A1 (en) 1983-11-01
AT380256B (en) 1986-05-12
GEP19960641B (en) 1996-11-15
UA5971A1 (en) 1994-12-29
HU186107B (en) 1985-06-28
LU84347A1 (en) 1983-06-07
IL66606A0 (en) 1982-12-31
SE8204817L (en) 1983-02-25
DE3231255C2 (en) 1992-02-27
LV5621A3 (en) 1994-05-10
NL990010I1 (en) 1999-07-01
JPH045029B2 (en) 1992-01-30
IT8222938A0 (en) 1982-08-23
LT2436B (en) 1994-02-15
ATA319182A (en) 1985-09-15
IE53408B1 (en) 1988-11-09
GB2104522B (en) 1985-06-12
NL990010I2 (en) 1999-09-01
AU571430B2 (en) 1988-04-21

Similar Documents

Publication Publication Date Title
FI822921L (en) PROCEDURE FOR FRAMSTATION OF AV / 3H / -IMIDAZO- / 5,1-D / -1,2,3,5-TETRAZINE-4-ONDERIVAT MED TERAPEUTISVERKAN
AR231138A1 (en) PROCEDURE FOR PREPARING DERIVATIVES OF 6 (7) -OXYRANYL-METOXI-7 (6) -METOXY OR OXYRANYL-METOXY-QUINAZOLINE
NO820083L (en) PROCEDURE FOR THE PREPARATION OF D-PHENYLALANYL-L-PROPYL-L-ARGINALDEHYDE SULFATE
NO821137L (en) PROCEDURE FOR THE PREPARATION OF TERTIARY ALKYLETERS
YU43077B (en) Process for the manufacture of substituted 1,2-diaminocyclo-butene-3,4-diones
IT1150897B (en) PROCESS FOR THE MANUFACTURE OF VULCANISTS
IT1152146B (en) PROCEDURE FOR THE PRODUCTION OF NEROFUMO
NO851524L (en) PROCEDURE FOR THE PREPARATION OF PHENETANOLAMINE COMPOUNDS
NO824019L (en) PROCEDURE FOR THE PREPARATION OF ALFA GALACTOXIDASE
RO86213A (en) PROCEDURE FOR THE PREPARATION OF IZOBUTENE
DE3278474D1 (en) Process for the preparation of di-galactose derivatives
NO823637L (en) PROCEDURE FOR THE PREPARATION OF EBURNAMONIN DERIVATIVES
NO822634L (en) PROCEDURE FOR THE MANUFACTURE OF CEFEM DERIVATIVES.
IT1154275B (en) PROCEDURE FOR THE PRODUCTION OF TIURAME DISULFURS
FI820598L (en) PROCEDURE FOR THE FRAMSTATION OF TREO-2-HYDROXY-3- (4-METHOXIFENYL) -3- (2-NITROPHENYLTHIO) -PROPIONSYRAESTER
YU49482A (en) Process for the manufacture of guanidine derivatives
NO820010L (en) ORGANOPOLYSILOXAN MIXTURES SUITABLE FOR THE PREPARATION OF ELASTOMERS
GB2152051B (en) Process for the preparation of azetidinone derivatives
EP0155710A3 (en) Process for the preparation of derivatives of polyethoxypropanesulfonates
PT74254A (en) Process for the preparation of pyridinyl-substituted-benzimidazole derivatives
NO820767L (en) PROCEDURE FOR THE PREPARATION OF TETRAHYDROPYRIDINE DERIVATIVES
FI820923L (en) PROCEDURE FOR THE FRAMSTATION OF AV 2-AMINO-5- (O-SULPHAMIDOPHENYL) -1,3,4-THIADIAZOLDERIVAT
JPS57181100A (en) Manufacture of 17 alpha-hydroxy-pregn-4-ene- 3,20-dione derivatives
NO822808L (en) PROCEDURE FOR THE PREPARATION OF DECARBOXYLASE-INHIBITED FLUORED ALKANDIAMINO DERIVATIVES
DE3260445D1 (en) Process for the preparation of 17-alpha-ethynyl-17-beta-trifluoroacetoxy-gon-4-en-3-one derivatives

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: CANCER RESEARCH CAMPAIGN TECHNOLOGY

SPCG Supplementary protection certificate granted

Spc suppl protection certif: L114

Extension date: 20070822

MA Patent expired

Owner name: CANCER RESEARCH CAMPAIGN TECHNOLOGY